Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Health Canada is proposing to prohibit the use of partially hydrogenated oils (PHOs), the main source of industrially produced trans …
Healthy eating is more than the foods you eat. It is also about where, when, why and how you eat.
…Regulatory Initiative: Amendments to the Food and Drug Regulations - Nutrition Labelling - Forward Regulatory Plan 2015-2017
Regulatory Initiative: Amendments to the Food and Drug Regulations Division 15 and 16 Clean Up for Food Additives - Forward …
As part of the Healthy Eating Strategy, Health Canada is proposing to restrict the marketing of unhealthy food and beverages …
Health Canada develops food safety and nutritional regulations, policies and guidance under the Food and Drugs Act. This act governs …
It presents the Patent Act Schedules #1, #2, #3 and #4.
Canada's Access to Medicines Regime is intended to address public health problems afflicting many developing and least-developed countries, especially those …
Canada's Access to Medicines Regime provides a framework within which eligible countries can import less expensive generic versions of patented …
This document provides guidance on the study and analysis of sex differences in clinical trials of therapeutic products in order …